Cumberland Pharmaceuticals (NASDAQ:CPIX) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research report released on Tuesday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Cumberland Pharmaceuticals Stock Performance NASDAQ:CPIX traded down $0.00 during trading hours on Tuesday, reaching $1.43. The company had a trading volume of 702 shares, […]

Leave a Reply

Your email address will not be published.

Previous post CSX (NASDAQ:CSX) Earns “Outperform” Rating from BMO Capital Markets
Next post China Natural Resources (NASDAQ:CHNR) Earns Sell Rating from Analysts at StockNews.com